Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives ...

There is a growing need for additional treatment options for individuals with type 2 diabetes who are being treated with ...

Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...